Leap Therapeutics Stock Probability of Future Stock Price Finishing Under 2.52
| LPTX Stock | USD 2.52 0.03 1.18% |
Leap |
Leap Therapeutics Target Price Odds to finish below 2.52
The tendency of Leap Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 2.52 | 90 days | 2.52 | about 21.35 |
Based on a normal probability distribution, the odds of Leap Therapeutics to move below current price in 90 days from now is about 21.35 (This Leap Therapeutics probability density function shows the probability of Leap Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Leap Therapeutics has a beta of 0.98. This indicates Leap Therapeutics market returns are sensitive to returns on the market. As the market goes up or down, Leap Therapeutics is expected to follow. Additionally Leap Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Leap Therapeutics Price Density |
| Price |
Predictive Modules for Leap Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Leap Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Leap Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Leap Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Leap Therapeutics is not an exception. The market had few large corrections towards the Leap Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Leap Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Leap Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.11 | |
β | Beta against Dow Jones | 0.98 | |
σ | Overall volatility | 0.48 | |
Ir | Information ratio | -0.02 |
Leap Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Leap Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Leap Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Leap Therapeutics generated a negative expected return over the last 90 days | |
| Leap Therapeutics has high historical volatility and very poor performance | |
| Net Loss for the year was (81.41 M) with profit before overhead, payroll, taxes, and interest of 1.5 M. | |
| Leap Therapeutics currently holds about 90.88 M in cash with (43.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92. | |
| Leap Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Simplify Asset Management Inc. Acquires 425,626 Shares of Leap Therapeutics, Inc. - MarketBeat |
Leap Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Leap Stock often depends not only on the future outlook of the current and potential Leap Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Leap Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 20.4 M | |
| Cash And Short Term Investments | 70.6 M |
Leap Therapeutics Technical Analysis
Leap Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Leap Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Leap Therapeutics. In general, you should focus on analyzing Leap Stock price patterns and their correlations with different microeconomic environments and drivers.
Leap Therapeutics Predictive Forecast Models
Leap Therapeutics' time-series forecasting models is one of many Leap Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Leap Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Leap Therapeutics
Checking the ongoing alerts about Leap Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Leap Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Leap Therapeutics generated a negative expected return over the last 90 days | |
| Leap Therapeutics has high historical volatility and very poor performance | |
| Net Loss for the year was (81.41 M) with profit before overhead, payroll, taxes, and interest of 1.5 M. | |
| Leap Therapeutics currently holds about 90.88 M in cash with (43.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92. | |
| Leap Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Simplify Asset Management Inc. Acquires 425,626 Shares of Leap Therapeutics, Inc. - MarketBeat |
Additional Tools for Leap Stock Analysis
When running Leap Therapeutics' price analysis, check to measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.